Attached files
| file | filename |
|---|---|
| 8-K - 8-K - AMERISOURCEBERGEN CORP | a13-24861_78k.htm |
| EX-99.1 - EX-99.1 - AMERISOURCEBERGEN CORP | a13-24861_7ex99d1.htm |
Exhibit 99.2
AMERISOURCEBERGEN CORPORATION
SUMMARY SEGMENT INFORMATION
(dollars in thousands)
(unaudited)
|
|
|
Revenue |
| ||||||||||||||||
|
|
|
Three months ended |
|
Fiscal year ended |
|
Fiscal year ended |
| ||||||||||||
|
|
|
December 31, 2012 |
|
March 31, 2013 |
|
June 30, 2013 |
|
September 30, 2013 |
|
September 30, 2013 |
|
September 30, 2012 |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
Pharmaceutical Distribution |
|
$ |
20,599,048 |
|
$ |
20,054,159 |
|
$ |
21,407,853 |
|
$ |
24,002,471 |
|
$ |
86,063,531 |
|
$ |
76,689,550 |
|
|
Other |
|
505,050 |
|
514,942 |
|
549,400 |
|
518,576 |
|
2,087,968 |
|
1,575,738 |
| ||||||
|
Intersegment eliminations |
|
(44,287 |
) |
(45,433 |
) |
(50,605 |
) |
(52,007 |
) |
(192,332 |
) |
(184,482 |
) | ||||||
|
Revenue |
|
$ |
21,059,811 |
|
$ |
20,523,668 |
|
$ |
21,906,648 |
|
$ |
24,469,040 |
|
$ |
87,959,167 |
|
$ |
78,080,806 |
|
|
|
|
Operating Income |
| ||||||||||||||||
|
|
|
Three months ended |
|
Fiscal year ended |
|
Fiscal year ended |
| ||||||||||||
|
|
|
December 31, 2012 |
|
March 31, 2013 |
|
June 30, 2013 |
|
September 30, 2013 |
|
September 30, 2013 |
|
September 30, 2012 |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
Pharmaceutical Distribution |
|
$ |
266,677 |
|
$ |
321,077 |
|
$ |
278,728 |
|
$ |
295,870 |
|
$ |
1,162,352 |
|
$ |
1,254,386 |
|
|
Other |
|
29,725 |
|
34,935 |
|
33,600 |
|
29,814 |
|
128,074 |
|
97,716 |
| ||||||
|
Gain on antitrust litigation settlements |
|
12,308 |
|
3,456 |
|
5,984 |
|
1,135 |
|
22,883 |
|
14,813 |
| ||||||
|
LIFO (expense) credit |
|
(1,167 |
) |
215 |
|
(122,077 |
) |
(153,972 |
) |
(277,001 |
) |
(706 |
) | ||||||
|
Acquisition related intangibles amortization |
|
(6,099 |
) |
(6,098 |
) |
(6,096 |
) |
(6,094 |
) |
(24,387 |
) |
(18,454 |
) | ||||||
|
Warrant expense |
|
— |
|
(3,761 |
) |
(35,815 |
) |
(50,479 |
) |
(90,055 |
) |
— |
| ||||||
|
Employee severance, litigation and other |
|
(2,004 |
) |
299 |
|
(19,678 |
) |
(2,084 |
) |
(23,467 |
) |
(44,140 |
) | ||||||
|
Operating income |
|
$ |
299,440 |
|
$ |
350,123 |
|
$ |
134,646 |
|
$ |
114,190 |
|
$ |
898,399 |
|
$ |
1,303,615 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
Operating Margins: |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
Pharmaceutical Distribution |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
- Gross Profit |
|
2.56% |
|
2.93% |
|
2.58% |
|
2.52% |
|
2.64% |
|
3.03% |
| ||||||
|
- Operating Expenses |
|
1.27% |
|
1.33% |
|
1.28% |
|
1.29% |
|
1.29% |
|
1.39% |
| ||||||
|
- Operating Income |
|
1.29% |
|
1.60% |
|
1.30% |
|
1.23% |
|
1.35% |
|
1.64% |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
- Gross Profit |
|
24.07% |
|
24.40% |
|
23.04% |
|
22.25% |
|
23.43% |
|
18.87% |
| ||||||
|
- Operating Expenses |
|
18.18% |
|
17.61% |
|
16.92% |
|
16.51% |
|
17.29% |
|
12.67% |
| ||||||
|
- Operating Income |
|
5.89% |
|
6.78% |
|
6.12% |
|
5.75% |
|
6.13% |
|
6.20% |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
AmerisourceBergen Corporation (GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
- Gross Profit |
|
3.14% |
|
3.49% |
|
2.57% |
|
2.32% |
|
2.85% |
|
3.37% |
| ||||||
|
- Operating Expenses |
|
1.72% |
|
1.79% |
|
1.95% |
|
1.85% |
|
1.83% |
|
1.70% |
| ||||||
|
- Operating Income |
|
1.42% |
|
1.71% |
|
0.61% |
|
0.47% |
|
1.02% |
|
1.67% |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
AmerisourceBergen Corporation (Non-GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
- Gross Profit |
|
3.08% |
|
3.48% |
|
3.10% |
|
2.94% |
|
3.14% |
|
3.36% |
| ||||||
|
- Operating Expenses |
|
1.68% |
|
1.74% |
|
1.67% |
|
1.61% |
|
1.67% |
|
1.62% |
| ||||||
|
- Operating Income |
|
1.41% |
|
1.73% |
|
1.43% |
|
1.33% |
|
1.47% |
|
1.73% |
| ||||||